First National Bank of Omaha’s Supernus Pharmaceuticals SUPN Stock Holding History

First National Bank of Omaha’s Portfolio SUPN Stock Details SUPN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-8,965	Closed	-$283K	–	322
2025 Q2	$283K	Sell	8,965 -227	-2%	-$7.28K	0.02%	294
2025 Q1	$301K	Buy	9,192 +34	+0.4%	+$1.21K	0.02%	286
2024 Q4	$331K	Sell	9,158 -904	-9%	-$31.8K	0.02%	283
2024 Q3	$314K	Sell	10,062 -352	-3%	-$11K	0.02%	283
2024 Q2	$279K	Buy	10,414 +1,222	+13%	+$35.4K	0.02%	288
2024 Q1	$301K	Sell	9,192 -3,473	-27%	-$103K	0.02%	286
2023 Q4	$367K	Sell	12,665 -1,517	-11%	-$40.2K	0.02%	284
2023 Q3	$391K	Sell	14,182 -264	-2%	-$8.04K	0.03%	281
2023 Q2	$434K	Hold	14,446	–	–	0.02%	276
2023 Q1	$523K	Sell	14,446 -580	-4%	-$22.3K	0.03%	259
2022 Q4	$536K	Sell	15,026 -1,370	-8%	-$47.6K	0.03%	264
2022 Q3	$555K	Sell	16,396 -637	-4%	-$20.7K	0.04%	255
2022 Q2	$493K	Buy	17,033 +662	+4%	+$19K	0.03%	270
2022 Q1	$529K	Sell	16,371 -5,805	-26%	-$178K	0.03%	269
2021 Q4	$647K	Sell	22,176 -1,778	-7%	-$53.9K	0.03%	265
2021 Q3	$639K	Buy	23,954 +851	+4%	+$22.8K	0.03%	264
2021 Q2	$605K	Hold	23,103	–	–	0.03%	269
2021 Q1	$605K	Buy	+23,103	New	+$646K	0.03%	269

Other funds holding SUPN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

First National Bank of Omaha's SUPN Position: Q3 2025 in Review

First National Bank of Omaha sold out of Supernus Pharmaceuticals (SUPN) in Q3 2025, closing a stake of 8,965 shares — an estimated $283K sold.

First National Bank of Omaha first reported a position in SUPN in Q1 2021 and held it in 18 quarters. The position peaked at $647K in Q4 2021. 310 funds tracked by Wall St. Rank hold SUPN as of Q3 2025.

First National Bank of Omaha reported no remaining Supernus Pharmaceuticals position as of Q3 2025 after selling out during the quarter.
First National Bank of Omaha sold 8,965 Supernus Pharmaceuticals shares in Q3 2025, an estimated $283K.
First National Bank of Omaha first reported a position in Supernus Pharmaceuticals in Q1 2021 and held it in 18 quarters.
First National Bank of Omaha's Supernus Pharmaceuticals position peaked at $647K in Q4 2021.
310 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q3 2025.

Based on First National Bank of Omaha's 13F filing for Q3 2025, filed 7 Nov 2025.